Tatsis Ourania

EVP, Chief Reg. & Quality Off.

Tatsis Ourania has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jul 23, 2026.

On the most recent filing, Tatsis Ourania is listed as EVP, Chief Reg. & Quality Off. at VERTEX PHARMACEUTICALS INC / MA. Inside the rolling window, Tatsis Ourania reported no open-market purchases and 8 open-market sales totaling $6.5M in VRTX. The largest disclosed transaction in the window is a sale of 4,500 VRTX shares on Jan 7, 2026, worth $2.1M.

Companies traded

Other insiders at VRTX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.5M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
VRTXSale$787KJul 7SEC ↗
VRTXSale$126KFeb 26SEC ↗
VRTXSale$298KFeb 19SEC ↗
VRTXSale$174KFeb 19SEC ↗
VRTXSale$750KFeb 18SEC ↗
VRTXSale$215KFeb 12SEC ↗
VRTXSale$2.1MJan 9SEC ↗
VRTXSale$2.0MDec 5SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Tatsis Ourania made?

Tatsis Ourania has filed 9 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Tatsis Ourania trade?

Tatsis Ourania has filed SEC Form 4 disclosures for 1 company, including VRTX.

When was Tatsis Ourania's most recent SEC Form 4 filing?

Tatsis Ourania's most recent SEC Form 4 filing on Tracefour is dated Jul 23, 2026.

What is Tatsis Ourania's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Tatsis Ourania is listed as EVP, Chief Reg. & Quality Off..

What is Tatsis Ourania's total buy and sell value in the current window?

Inside the rolling retention window, Tatsis Ourania bought $0 and sold $6.5M based on SEC Form 4 filings.

What was Tatsis Ourania's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 4,500 VRTX shares on 2026-01-07, worth $2.1M, per SEC Form 4 filings.